Safety of Flash Sensor-based Glucose Monitoring in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
Phase 1
- Conditions
- Hematological disorder
- Registration Number
- JPRN-UMIN000027845
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who will undergo HLA haplo-identical stem cell transplantation Patients who need to perform X-ray or CT scan more than once a week Patients who have infection on their upper arms for sensor sites Patients with contact dermatitis Patients who cannot use alcohol and chlorhexidine gluconate for sterilization Patients who have implanted medical devices Patients judged inappropriate participants for this study by their attending doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severe bleeding of the sensor site Requirement of antibiotics due to the infection of the sensor site
- Secondary Outcome Measures
Name Time Method Insertion site symptoms Correlation with the value of blood glucose and interstitial fluid glucose The times of the sensor exchanges Overall survival and progression free survival at days 100